NeoStem, Inc. (NBS) Starts Presentation at 2nd Annual Marcum MicroCap Conference
NeoStem is engaged in the emerging cellular therapy industry, leveraging a business model that includes the development of novel proprietary cell therapy products as well as operating a contract development and manufacturing organization (“CDMO”) providing services to clients advancing regenerative medicine product candidates in the regenerative medicine industry; adult stem cell collection and storage services; and therapy development utilizing T-cells for autoimmune and inflammatory conditions. For more information visit the company’s Web site at www.neostem.com
Let us hear your thoughts below:
The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in
Marcum MicroCap. Bookmark the
permalink.
